Tekla Healthcare Opportunities Fund announces a share repurchase program. Under the program, the company will repurchase up to 12% of its outstanding common shares. The shares will be purchased in open market. The company aims to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the net asset value per share. The share repurchase program is intended to increase the Fund's net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares. The amount and timing of repurchases will be at the discretion of Tekla Capital Management LLC, the investment adviser to the Fund. There is no assurance that the Fund will purchase shares at any specific discount levels or in any specific amounts or on any specific date. There is no assurance that the market price of the Fund's shares, either absolute or relative to net asset value, will increase as a result of any share repurchases. The program will run for a one year period ending July 14, 2018.